{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T23:25:59Z","timestamp":1792797959278,"version":"4.5.0"},"reference-count":158,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T00:00:00Z","timestamp":1766016000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","award":["IZSEZ0_229208"],"award-info":[{"award-number":["IZSEZ0_229208"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006387","name":"Fondation Leenaards","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006387","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006392","name":"Centre Hospitalier Universitaire Vaudois","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006392","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008947","name":"Stiftung Synapsis - Alzheimer Forschung Schweiz AFS","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008947","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ageing Research Reviews"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.arr.2025.103001","type":"journal-article","created":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T06:00:58Z","timestamp":1766124058000},"page":"103001","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Targeting brain connectivity in Alzheimer\u2019s disease with repurposed drugs"],"prefix":"10.1016","volume":"114","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9305-3376","authenticated-orcid":false,"given":"Lorenzo","family":"Pini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno P.","family":"Imbimbo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Griffa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilles","family":"Allali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nunzio","family":"Pomara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.arr.2025.103001_bib1","first-page":"566","article-title":"Prefrontal connectivity and glutamate transmission: relevance to depression pathophysiology and ketamine treatment","volume":"2","author":"Abdallah","year":"2017","journal-title":"Biol. Psychiatry Cogn. Neurosci."},{"key":"10.1016\/j.arr.2025.103001_bib2","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.1038\/s41380-022-01502-0","article-title":"Validation of ketamine as a pharmacological model of thalamic dysconnectivity across the illness course of schizophrenia","volume":"27","author":"Abram","year":"2022","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.arr.2025.103001_bib3","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1007\/s11011-014-9507-6","article-title":"Enhancement of functional connectivity, working memory and inhibitory control on multi-modal brain MR imaging with Rifaximin in Cirrhosis: implications for the gut-liver-brain axis","volume":"29","author":"Ahluwalia","year":"2014","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.arr.2025.103001_bib4","article-title":"The case for regulatory approval of amyloid-lowering immunotherapies in Alzheimer\u2019s disease based on clearcut biomarker evidence","volume":"21","author":"Aisen","year":"2025","journal-title":"Alzheimer\u2019S. Dem"},{"key":"10.1016\/j.arr.2025.103001_bib5","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1007\/s11011-021-00888-0","article-title":"Beneficial effects of levetiracetam in streptozotocin-induced rat model of Alzheimer\u2019s disease","volume":"37","author":"Alavi","year":"2022","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.arr.2025.103001_bib6","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.38744","article-title":"Metformin reverses early cortical network dysfunction and behavior changes in Huntington\u2019s disease","volume":"7","author":"Arnoux","year":"2018","journal-title":"eLife"},{"key":"10.1016\/j.arr.2025.103001_bib7","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.4103\/1673-5374.361541","article-title":"Functional hyperconnectivity related to brain disease: maladaptive process or element of resilience?","volume":"18","author":"Aswendt","year":"2023","journal-title":"Neural Regen. Res"},{"key":"10.1016\/j.arr.2025.103001_bib8","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.jad.2024.11.019","article-title":"A systematic review in effects of glucagon-like peptide-1 (GLP-1) mono-agonists on functional connectivity: target engagement and rationale for the development in mental disorders","volume":"370","author":"Au","year":"2025","journal-title":"J. Aff. Disord."},{"key":"10.1016\/j.arr.2025.103001_bib9","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.neuron.2012.03.023","article-title":"Reduction of hippocampal hyperactivity improves cognition in amnestic mild cognitive impairment","volume":"74","author":"Bakker","year":"2012","journal-title":"Neuron"},{"key":"10.1016\/j.arr.2025.103001_bib10","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/j.nicl.2015.02.009","article-title":"Response of the medial temporal lobe network in amnestic mild cognitive impairment to therapeutic intervention assessed by fMRI and memory task performance","volume":"7","author":"Bakker","year":"2015","journal-title":"NeuroImage Clin."},{"key":"10.1016\/j.arr.2025.103001_bib11","article-title":"The HOPE4MCI study: AGB101 treatment slows progression of entorhinal cortex atrophy in APOE \u03b54 non-carriers with mild cognitive impairment due to Alzheimer\u2019s disease","volume":"10","author":"Bakker","year":"2024","journal-title":"AampD. Transl. Res amp Clin. Inter."},{"key":"10.1016\/j.arr.2025.103001_bib12","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s13195-023-01355-x","article-title":"A multimodal precision-prevention approach combining lifestyle intervention with metformin repurposing to prevent cognitive impairment and disability: the MET-FINGER randomised controlled trial protocol","volume":"16","author":"Barbera","year":"2024","journal-title":"Alz Res Ther."},{"key":"10.1016\/j.arr.2025.103001_bib13","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1002\/path.5056","article-title":"The diabetes drug liraglutide reverses cognitive impairment in mice and attenuates insulin receptor and synaptic pathology in a non-human primate model of Alzheimer\u2019s disease","volume":"245","author":"Batista","year":"2018","journal-title":"J. Pathol."},{"key":"10.1016\/j.arr.2025.103001_bib14","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.neuroimage.2017.02.049","article-title":"General and emotion-specific neural effects of ketamine during emotional memory formation","volume":"150","author":"Becker","year":"2017","journal-title":"NeuroImage"},{"key":"10.1016\/j.arr.2025.103001_bib15","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1007\/s12035-020-02142-7","article-title":"Mitochondria-targeted small peptide, SS31 ameliorates diabetes induced mitochondrial dynamics in male TallyHO\/JngJ Mice","volume":"58","author":"Bhatti","year":"2021","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.arr.2025.103001_bib16","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1056\/NEJM200008173430701","article-title":"Patterns of brain activation in people at risk for Alzheimer\u2019s disease","volume":"343","author":"Bookheimer","year":"2000","journal-title":"N. Engl. J. Med"},{"key":"10.1016\/j.arr.2025.103001_bib17","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/s41586-020-2314-9","article-title":"Variability in the analysis of a single neuroimaging dataset by many teams","volume":"582","author":"Botvinik-Nezer","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.arr.2025.103001_bib18","doi-asserted-by":"crossref","unstructured":"Burton, C.P., Chumin, E.J., Collins, A.Y., Persohn, S.A., Onos, K.D., Pandey, R.S., Quinney, S.K., Territo, P.R.., 2023. Levetiracetam Modulates Brain Metabolic Networks and Transcriptomic Signatures in the 5XFAD Mouse Model of Alzheimer\u2019s disease. https:\/\/doi.org\/10.1101\/2023.11.10.566574.","DOI":"10.1101\/2023.11.10.566574"},{"key":"10.1016\/j.arr.2025.103001_bib19","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1212\/WNL.0000000000001617","article-title":"Etanercept in Alzheimer disease: a randomized, placebo-controlled, double-blind, phase 2 trial","volume":"84","author":"Butchart","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.arr.2025.103001_bib20","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/s41583-019-0132-6","article-title":"Oxidative stress, dysfunctional glucose metabolism and Alzheimer disease","volume":"20","author":"Butterfield","year":"2019","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.arr.2025.103001_bib21","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/s41583-018-0068-2","article-title":"Maintenance, reserve and compensation: the cognitive neuroscience of healthy ageing","volume":"19","author":"Cabeza","year":"2018","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.arr.2025.103001_bib22","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1038\/s41380-018-0235-x","article-title":"Increased macrophages and changed brain endothelial cell gene expression in the frontal cortex of people with schizophrenia displaying inflammation","volume":"25","author":"Cai","year":"2020","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.arr.2025.103001_bib23","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/S0889-1591(02)00007-7","article-title":"Treatment of cytokine-induced depression","volume":"16","author":"Capuron","year":"2002","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.arr.2025.103001_bib24","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/S0006-3223(03)00173-2","article-title":"Interferon-alpha\u2013induced changes in tryptophan metabolism","volume":"54","author":"Capuron","year":"2003","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.arr.2025.103001_bib25","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.jad.2009.02.017","article-title":"Does cytokine-induced depression differ from idiopathic major depression in medically healthy individuals?","volume":"119","author":"Capuron","year":"2009","journal-title":"J. Aff. Disord."},{"key":"10.1016\/j.arr.2025.103001_bib26","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1001\/archgenpsychiatry.2011.2094","article-title":"Dopaminergic Mechanisms of Reduced Basal Ganglia Responses to Hedonic Reward During Interferon Alfa Administration","volume":"69","author":"Capuron","year":"2012","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.arr.2025.103001_bib27","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s12967-023-04844-7","article-title":"Improved cognition after rifaximin treatment is associated with changes in intra- and inter-brain network functional connectivity","volume":"22","author":"Casanova-Ferrer","year":"2024","journal-title":"J. Transl. Med"},{"key":"10.1016\/j.arr.2025.103001_bib28","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.neurobiolaging.2016.08.019","article-title":"Association of brain amyloidosis with pro-inflammatory gut bacterial taxa and peripheral inflammation markers in cognitively impaired elderly","volume":"49","author":"Cattaneo","year":"2017","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.arr.2025.103001_bib29","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s13024-023-00595-7","article-title":"The gut microbiome in Alzheimer\u2019s disease: what we know and what remains to be explored","volume":"18","author":"Chandra","year":"2023","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.arr.2025.103001_bib30","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.jocn.2020.09.054","article-title":"Semaglutide-mediated protection against A\u03b2 correlated with enhancement of autophagy and inhibition of apotosis","volume":"81","author":"Chang","year":"2020","journal-title":"J. Clin. Neurosci."},{"key":"10.1016\/j.arr.2025.103001_bib31","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.1007\/s11064-017-2250-8","article-title":"Liraglutide improves water maze learning and memory performance while reduces hyperphosphorylation of tau and neurofilaments in APP\/PS1\/Tau Triple Transgenic Mice","volume":"42","author":"Chen","year":"2017","journal-title":"Neurochem. Res"},{"key":"10.1016\/j.arr.2025.103001_bib32","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.2337\/dc21-2064","article-title":"Enhancement of Impaired Olfactory Neural Activation and Cognitive Capacity by Liraglutide, but Not Dapagliflozin or Acarbose, in Patients With Type 2 Diabetes: A 16-Week Randomized Parallel Comparative Study","volume":"45","author":"Cheng","year":"2022","journal-title":"Diabetes Care"},{"key":"10.1016\/j.arr.2025.103001_bib33","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/s41398-024-02755-9","article-title":"Reconsidering repurposing: long-term metformin treatment impairs cognition in Alzheimer\u2019s model mice","volume":"14","author":"Cho","year":"2024","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.arr.2025.103001_bib34","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/nature09635","article-title":"Reversing EphB2 depletion rescues cognitive functions in Alzheimer model","volume":"469","author":"Ciss\u00e9","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.arr.2025.103001_bib35","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1038\/nrd3869","article-title":"Drug repositioning for Alzheimer\u2019s disease","volume":"11","author":"Corbett","year":"2012","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.arr.2025.103001_bib36","doi-asserted-by":"crossref","DOI":"10.1093\/braincomms\/fcae376","article-title":"Cerebral hyperactivation across the Alzheimer\u2019s disease pathological cascade","volume":"6","author":"Corriveau-Lecavalier","year":"2024","journal-title":"Brain Commun."},{"key":"10.1016\/j.arr.2025.103001_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2025.102713","article-title":"Mitochondrial dysfunction in Alzheimer\u2019s disease","volume":"107","author":"D\u2019Alessandro","year":"2025","journal-title":"Ageing Res Rev."},{"key":"10.1016\/j.arr.2025.103001_bib38","doi-asserted-by":"crossref","first-page":"5150","DOI":"10.1038\/s41380-020-0790-9","article-title":"Interferon and anti-TNF therapies differentially modulate amygdala reactivity which predicts associated bidirectional changes in depressive symptoms","volume":"26","author":"Davies","year":"2021","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.arr.2025.103001_bib39","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/s41586-018-0784-9","article-title":"L1 drives IFN in senescent cells and promotes age-associated inflammation","volume":"566","author":"De Cecco","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.arr.2025.103001_bib40","doi-asserted-by":"crossref","first-page":"412","DOI":"10.2174\/1567205013666160930110551","article-title":"Targeting Tumor Necrosis Factor Alpha for Alzheimer\u2019s Disease","volume":"14","author":"Decourt","year":"2017","journal-title":"CAR"},{"key":"10.1016\/j.arr.2025.103001_bib41","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1212\/01.wnl.0000171450.97464.49","article-title":"Increased hippocampal activation in mild cognitive impairment compared to normal aging and AD","volume":"65","author":"Dickerson","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.arr.2025.103001_bib42","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2022.838173","article-title":"Exploring the pharmacological potential of metformin for neurodegenerative diseases","volume":"14","author":"Du","year":"2022","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.arr.2025.103001_bib43","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1001\/jamaneurol.2024.3770","article-title":"Alzheimer Disease as a Clinical-Biological Construct\u2014An International Working Group Recommendation","volume":"81","author":"Dubois","year":"2024","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.arr.2025.103001_bib44","article-title":"Liraglutide in mild to moderate Alzheimer\u2019s disease: a phase 2b clinical trial","author":"Edison","year":"2025","journal-title":"Nat. Med"},{"key":"10.1016\/j.arr.2025.103001_bib45","article-title":"TNF-alpha Modulation for Treatment of Alzheimer\u2019s Disease: A 6-Month Pilot Study","volume":"25","author":"Edward","year":"2006","journal-title":"MedGenMed"},{"key":"10.1016\/j.arr.2025.103001_bib46","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1186\/s13063-019-3259-x","article-title":"Evaluating the effects of the novel GLP-1 analogue liraglutide in Alzheimer\u2019s disease: study protocol for a randomised controlled trial (ELAD study)","volume":"20","author":"Femminella","year":"2019","journal-title":"Trials"},{"key":"10.1016\/j.arr.2025.103001_bib47","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abo2984","article-title":"Gut microbiome composition may be an indicator of preclinical Alzheimer\u2019s disease","volume":"15","author":"Ferreiro","year":"2023","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.arr.2025.103001_bib48","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/s41583-021-00533-w","article-title":"The probabilistic model of Alzheimer disease: the amyloid hypothesis revised","volume":"23","author":"Frisoni","year":"2022","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.arr.2025.103001_bib49","doi-asserted-by":"crossref","first-page":"189","DOI":"10.4103\/1673-5374.343888","article-title":"Lamotrigine protects against cognitive deficits, synapse and nerve cell damage, and hallmark neuropathologies in a mouse model of Alzheimer\u2019s disease","volume":"18","author":"Fu","year":"2023","journal-title":"Neural Regen. Res"},{"key":"10.1016\/j.arr.2025.103001_bib50","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.133429","article-title":"Semaglutide lowers body weight in rodents via distributed neural pathways","volume":"5","author":"Gabery","year":"2020","journal-title":"JCI Insight"},{"key":"10.1016\/j.arr.2025.103001_bib51","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1159\/000528315","article-title":"Modulatory Effects of Ketamine and Lamotrigine on Cognition: Emotion Interaction in the Brain","volume":"82","author":"G\u00e4rtner","year":"2023","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.arr.2025.103001_bib52","doi-asserted-by":"crossref","DOI":"10.3389\/fnene.2013.00002","article-title":"Glucagon-like peptide-1 (GLP-1) raises blood-brain glucose transfer capacity and hexokinase activity in human brain","volume":"5","author":"Gejl","year":"2013","journal-title":"Front. Neuroenergetics"},{"key":"10.1016\/j.arr.2025.103001_bib53","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2016.00108","article-title":"In Alzheimer\u2019s Disease, 6-Month Treatment with GLP-1 Analog Prevents Decline of Brain Glucose Metabolism: Randomized, Placebo-Controlled, Double-Blind Clinical Trial","volume":"8","author":"Gejl","year":"2016","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.arr.2025.103001_bib54","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.biopsych.2022.11.003","article-title":"Inflammation-Related Functional and Structural Dysconnectivity as a Pathway to Psychopathology","volume":"93","author":"Goldsmith","year":"2023","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.arr.2025.103001_bib55","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1007\/s13311-017-0541-z","article-title":"Targeting Neural Hyperactivity as a Treatment to Stem Progression of Late-Onset Alzheimer\u2019s Disease","volume":"14","author":"Haberman","year":"2017","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.arr.2025.103001_bib56","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.neurobiolaging.2016.12.021","article-title":"Heightened cortical excitability in aged rodents with memory impairment","volume":"54","author":"Haberman","year":"2017","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.arr.2025.103001_bib57","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.neurobiolaging.2012.04.009","article-title":"Liraglutide protects against amyloid-\u03b2 protein-induced impairment of spatial learning and memory in rats","volume":"34","author":"Han","year":"2013","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.arr.2025.103001_bib58","doi-asserted-by":"crossref","first-page":"877","DOI":"10.3233\/JAD-143090","article-title":"The GLP-1 Receptor Agonist Liraglutide Improves Memory Function and Increases Hippocampal CA1 Neuronal Numbers in a Senescence-Accelerated Mouse Model of Alzheimer\u2019s Disease","volume":"46","author":"Hansen","year":"2015","journal-title":"JAD"},{"key":"10.1016\/j.arr.2025.103001_bib59","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0158205","article-title":"Long-Term Treatment with Liraglutide, a Glucagon-Like Peptide-1 (GLP-1) Receptor Agonist, Has No Effect on \u03b2-Amyloid Plaque Load in Two Transgenic APP\/PS1 Mouse Models of Alzheimer\u2019s Disease","volume":"11","author":"Hansen","year":"2016","journal-title":"PLoS ONE"},{"key":"10.1016\/j.arr.2025.103001_bib60","doi-asserted-by":"crossref","first-page":"2696","DOI":"10.1016\/j.jstrokecerebrovasdis.2018.05.039","article-title":"Liraglutide Protects Neurite Outgrowth of Cortical Neurons Under Oxidative Stress though Activating the Wnt Pathway","volume":"27","author":"He","year":"2018","journal-title":"J. Stroke Cereb. Dis."},{"key":"10.1016\/j.arr.2025.103001_bib61","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1002\/1097-0029(20000801)50:3<184::AID-JEMT2>3.0.CO;2-H","article-title":"TNF? and the TNF receptor superfamily: Structure-function relationship(s)","volume":"50","author":"Idriss","year":"2000","journal-title":"Microsc. Res. Tech."},{"key":"10.1016\/j.arr.2025.103001_bib62","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.3390\/ph16121714","article-title":"Metformin: the winding path from understanding its molecular mechanisms to proving therapeutic benefits in neurodegenerative disorders","volume":"16","author":"Isop","year":"2023","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.arr.2025.103001_bib63","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1212\/WNL.0000000000002923","article-title":"A\/T\/N: An unbiased descriptive classification scheme for Alzheimer disease biomarkers","volume":"87","author":"Jack","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.arr.2025.103001_bib64","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1093\/brain\/awv338","article-title":"Cascading network failure across the Alzheimer\u2019s disease spectrum","volume":"139","author":"Jones","year":"2016","journal-title":"Brain"},{"key":"10.1016\/j.arr.2025.103001_bib65","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1111\/hepr.13300","article-title":"Rifaximin-altered gut microbiota components associated with liver\/neuropsychological functions in patients with hepatic encephalopathy: An exploratory data analysis of phase II\/III clinical trials","volume":"49","author":"Kawaguchi","year":"2019","journal-title":"Hepatol. Res."},{"key":"10.1016\/j.arr.2025.103001_bib66","doi-asserted-by":"crossref","first-page":"13604","DOI":"10.3390\/ijms222413604","article-title":"Lamotrigine Attenuates Neuronal Excitability, Depresses GABA Synaptic Inhibition, and Modulates Theta Rhythms in Rat Hippocampus","volume":"22","author":"Kazmierska-Grebowska","year":"2021","journal-title":"IJMS"},{"key":"10.1016\/j.arr.2025.103001_bib67","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2022.114945","article-title":"Metformin in Alzheimer\u2019s disease: An overview of potential mechanisms, preclinical and clinical findings","volume":"197","author":"Khezri","year":"2022","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.arr.2025.103001_bib68","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.bbr.2016.06.001","article-title":"Infliximab ameliorates AD-associated object recognition memory impairment","volume":"311","author":"Kim","year":"2016","journal-title":"Behav. Brain Res"},{"key":"10.1016\/j.arr.2025.103001_bib69","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2023-081401","article-title":"Protocol for a double-blind placebo-controlled randomised controlled trial assessing the impact of oral semaglutide in amyloid positivity (ISAP) in community dwelling UK adults","volume":"14","author":"Koychev","year":"2024","journal-title":"BMJ Open"},{"key":"10.1016\/j.arr.2025.103001_bib70","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.acthis.2014.12.002","article-title":"Effects of systemic Thalidomide and intracerebroventricular Etanercept and Infliximab administration in a Streptozotocin induced dementia model in rats","volume":"117","author":"K\u00fcbra El\u00e7io\u011flu","year":"2015","journal-title":"Acta Histochem."},{"key":"10.1016\/j.arr.2025.103001_bib71","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s00234-023-03261-3","article-title":"Structural connectivity as a predictive factor for responsiveness to levetiracetam treatment in epilepsy","volume":"66","author":"Lee","year":"2024","journal-title":"Neuroradiology"},{"key":"10.1016\/j.arr.2025.103001_bib72","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.bbi.2020.04.063","article-title":"Efficacy of adjunctive infliximab vs. placebo in the treatment of anhedonia in bipolar I\/II depression","volume":"88","author":"Lee","year":"2020","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.arr.2025.103001_bib73","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1093\/scan\/nsw034","article-title":"Differential effects of rumination and distraction on ketamine induced modulation of resting state functional connectivity and reactivity of regions within the default-mode network","volume":"11","author":"Lehmann","year":"2016","journal-title":"Soc. Cogn. Affec Neurosci."},{"key":"10.1016\/j.arr.2025.103001_bib74","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1038\/s41380-022-01878-z","article-title":"Neuroinflammation is independently associated with brain network dysfunction in Alzheimer\u2019s disease","volume":"28","author":"Leng","year":"2023","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.arr.2025.103001_bib75","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.3390\/biomedicines10061263","article-title":"Rifaximin Improves Spatial Learning and Memory Impairment in Rats with Liver Damage-Associated Neuroinflammation","volume":"10","author":"Leone","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.arr.2025.103001_bib76","doi-asserted-by":"crossref","first-page":"8281","DOI":"10.3390\/ijms23158281","article-title":"Actions of Metformin in the Brain: A New Perspective of Metformin Treatments in Related Neurological Disorders","volume":"23","author":"Li","year":"2022","journal-title":"IJMS"},{"key":"10.1016\/j.arr.2025.103001_bib77","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1007\/s12017-012-8199-5","article-title":"The Diabetes Drug Liraglutide Ameliorates Aberrant Insulin Receptor Localisation and Signalling in Parallel with Decreasing Both Amyloid-\u03b2 Plaque and Glial Pathology in a Mouse Model of Alzheimer\u2019s Disease","volume":"15","author":"Long-Smith","year":"2013","journal-title":"Neuromol Med"},{"key":"10.1016\/j.arr.2025.103001_bib78","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1016\/j.cell.2013.05.039","article-title":"The Hallmarks of Aging","volume":"153","author":"L\u00f3pez-Ot\u00edn","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.arr.2025.103001_bib79","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/s41586-022-04431-8","article-title":"Low-dose metformin targets the lysosomal AMPK pathway through PEN2","volume":"603","author":"Ma","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.arr.2025.103001_bib80","doi-asserted-by":"crossref","first-page":"5689","DOI":"10.1007\/s12035-017-0795-9","article-title":"Systemic inflammation and multimodal biomarkers in amnestic mild cognitive impairment and Alzheimer\u2019s Disease","volume":"55","author":"Magalh\u00e3es","year":"2018","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.arr.2025.103001_bib81","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1038\/s41586-022-04492-9","article-title":"Reproducible brain-wide association studies require thousands of individuals","volume":"603","author":"Marek","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.arr.2025.103001_bib82","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.bbi.2017.01.013","article-title":"Systemic inflammation and resting state connectivity of the default mode network","volume":"62","author":"Marsland","year":"2017","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.arr.2025.103001_bib83","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1038\/ncomms3192","article-title":"Metformin improves healthspan and lifespan in mice","volume":"4","author":"Martin-Montalvo","year":"2013","journal-title":"Nat. Commun."},{"key":"10.1016\/j.arr.2025.103001_bib84","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.neuropharm.2013.08.005","article-title":"Liraglutide can reverse memory impairment, synaptic loss and reduce plaque load in aged APP\/PS1 mice, a model of Alzheimer\u2019s disease","volume":"76","author":"McClean","year":"2014","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.arr.2025.103001_bib85","doi-asserted-by":"crossref","first-page":"6587","DOI":"10.1523\/JNEUROSCI.0529-11.2011","article-title":"The Diabetes Drug Liraglutide Prevents Degenerative Processes in a Mouse Model of Alzheimer\u2019s Disease","volume":"31","author":"McClean","year":"2011","journal-title":"J. Neurosci."},{"key":"10.1016\/j.arr.2025.103001_bib86","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.bbr.2015.07.024","article-title":"Prophylactic liraglutide treatment prevents amyloid plaque deposition, chronic inflammation and memory impairment in APP\/PS1 mice","volume":"293","author":"McClean","year":"2015","journal-title":"Behav. Brain Res"},{"key":"10.1016\/j.arr.2025.103001_bib87","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/s41398-024-03120-6","article-title":"Functional activity and connectivity signatures of ketamine and lamotrigine during negative emotional processing: a double-blind randomized controlled fMRI study","volume":"14","author":"Meiering","year":"2024","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.arr.2025.103001_bib88","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/nri.2015.5","article-title":"The role of inflammation in depression: from evolutionary imperative to modern treatment target","volume":"16","author":"Miller","year":"2016","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.arr.2025.103001_bib89","doi-asserted-by":"crossref","first-page":"2611","DOI":"10.1016\/j.immuni.2021.10.006","article-title":"Prenatal interleukin 6 elevation increases glutamatergic synapse density and disrupts hippocampal connectivity in offspring","volume":"54","author":"Mirabella","year":"2021","journal-title":"Immunity"},{"key":"10.1016\/j.arr.2025.103001_bib90","article-title":"The HOPE4MCI study: A randomized double-blind assessment of AGB101 for the treatment of MCI due to AD","volume":"10","author":"Mohs","year":"2024","journal-title":"AD Transl. Res Clin. Inter."},{"key":"10.1016\/j.arr.2025.103001_bib91","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.freeradbiomed.2021.07.013","article-title":"Defective mitophagy and synaptic degeneration in Alzheimer\u2019s disease: Focus on aging, mitochondria and synapse","volume":"172","author":"Morton","year":"2021","journal-title":"Free Radic. Biol. Med"},{"key":"10.1016\/j.arr.2025.103001_bib92","doi-asserted-by":"crossref","first-page":"5037","DOI":"10.1038\/s41380-023-02146-4","article-title":"A systematic review exploring the association between the human gut microbiota and brain connectivity in health and disease","volume":"28","author":"Mulder","year":"2023","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.arr.2025.103001_bib93","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.3233\/JAD-160742","article-title":"Levetiracetam Alters Oscillatory Connectivity in Alzheimer\u2019s Disease","volume":"58","author":"Musaeus","year":"2017","journal-title":"JAD"},{"key":"10.1016\/j.arr.2025.103001_bib94","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1056\/NEJM200103293441303","article-title":"Paroxetine for the Prevention of Depression Induced by High-Dose Interferon Alfa","volume":"344","author":"Musselman","year":"2001","journal-title":"N. Engl. J. Med"},{"key":"10.1016\/j.arr.2025.103001_bib95","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s13195-020-00752-w","article-title":"Distinct network topology in Alzheimer\u2019s disease and behavioral variant frontotemporal dementia","volume":"13","author":"Ng","year":"2021","journal-title":"Alz Res Ther."},{"key":"10.1016\/j.arr.2025.103001_bib96","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1038\/s41398-021-01742-8","article-title":"A schizophrenia subgroup with elevated inflammation displays reduced microglia, increased peripheral immune cell and altered neurogenesis marker gene expression in the subependymal zone","volume":"11","author":"North","year":"2021","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.arr.2025.103001_bib97","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2024.102582","article-title":"Semaglutide as a possible therapy for healthy aging: Targeting the hallmarks of aging","volume":"102","author":"Ortiz","year":"2024","journal-title":"Ageing Res Rev."},{"key":"10.1016\/j.arr.2025.103001_bib98","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuroimage.2022.119280","article-title":"Variability of regional glucose metabolism and the topology of functional networks in the human brain","volume":"257","author":"Palombit","year":"2022","journal-title":"NeuroImage"},{"key":"10.1016\/j.arr.2025.103001_bib99","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1001\/archneurol.2009.15","article-title":"Epilepsy and Cognitive Impairments in Alzheimer Disease","volume":"66","author":"Palop","year":"2009","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.arr.2025.103001_bib100","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.neuron.2007.07.025","article-title":"Aberrant Excitatory Neuronal Activity and Compensatory Remodeling of Inhibitory Hippocampal Circuits in Mouse Models of Alzheimer\u2019s Disease","volume":"55","author":"Palop","year":"2007","journal-title":"Neuron"},{"key":"10.1016\/j.arr.2025.103001_bib101","series-title":"Modern Trends in Psychiatry","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1159\/000470809","article-title":"Inflammatory and Innate Immune Markers of Neuroprogression in Depressed and Teenage Suicide Brain","author":"Pandey","year":"2017"},{"key":"10.1016\/j.arr.2025.103001_bib102","doi-asserted-by":"crossref","first-page":"7218","DOI":"10.1523\/JNEUROSCI.2574-18.2019","article-title":"Neuroinflammation and Functional Connectivity in Alzheimer\u2019s Disease: Interactive Influences on Cognitive Performance","volume":"39","author":"Passamonti","year":"2019","journal-title":"J. Neurosci."},{"key":"10.1016\/j.arr.2025.103001_bib103","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1097\/WCO.0000000000000109","article-title":"FDG-PET and amyloid-PET imaging: the diverging paths","volume":"27","author":"Perani","year":"2014","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.arr.2025.103001_bib104","doi-asserted-by":"crossref","first-page":"825","DOI":"10.3233\/JAD-161105","article-title":"Coordinate-based meta-analysis of the default mode and salience network for target identification in non-invasive brain stimulation of Alzheimer\u2019s disease and behavioral variant frontotemporal dementia networks","volume":"57","author":"Pievani","year":"2017","journal-title":"JAD"},{"key":"10.1016\/j.arr.2025.103001_bib105","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1007\/s10620-017-4598-7","article-title":"Repeat rifaximin for irritable bowel syndrome: no clinically significant changes in stool microbial antibiotic sensitivity","volume":"62","author":"Pimentel","year":"2017","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.arr.2025.103001_bib106","doi-asserted-by":"crossref","first-page":"115","DOI":"10.4103\/1673-5374.340410","article-title":"Brain network modulation in Alzheimer\u2019s disease: clinical phenotypes and windows of opportunity","volume":"18","author":"Pini","year":"2023","journal-title":"Neural Regen. Res"},{"key":"10.1016\/j.arr.2025.103001_bib107","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.arr.2016.01.002","article-title":"Brain atrophy in Alzheimer\u2019s disease and aging","volume":"30","author":"Pini","year":"2016","journal-title":"Ageing Res Rev."},{"key":"10.1016\/j.arr.2025.103001_bib108","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2023.101867","article-title":"The pollutome-connectome axis: a putative mechanism to explain pollution effects on neurodegeneration","volume":"86","author":"Pini","year":"2023","journal-title":"Ageing Res Rev."},{"key":"10.1016\/j.arr.2025.103001_bib109","doi-asserted-by":"crossref","DOI":"10.1093\/braincomms\/fcae460","article-title":"Can brain network connectivity facilitate the clinical development of disease-modifying anti-Alzheimer drugs?","volume":"7","author":"Pini","year":"2024","journal-title":"Brain Commun."},{"key":"10.1016\/j.arr.2025.103001_bib110","article-title":"Brain connectivity as a new target for Alzheimer\u2019s disease therapy?","author":"Pini","year":"2025","journal-title":"Brain"},{"key":"10.1016\/j.arr.2025.103001_bib111","doi-asserted-by":"crossref","DOI":"10.1002\/alz.70068","article-title":"The science does not yet support regulatory approval of amyloid-targeting therapies for Alzheimer\u2019s disease based solely on biomarker evidence","volume":"21","author":"Planche","year":"2025","journal-title":"Alzheimer\u2019S. Dement"},{"key":"10.1016\/j.arr.2025.103001_bib112","doi-asserted-by":"crossref","first-page":"939","DOI":"10.3233\/JAD-220614","article-title":"Levetiracetam Increases Hippocampal Blood Flow in Alzheimer\u2019s Disease as Measured by Arterial Spin Labelling MRI","volume":"93","author":"Press","year":"2023","journal-title":"JAD"},{"key":"10.1016\/j.arr.2025.103001_bib113","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ejphar.2016.04.052","article-title":"Subcutaneous administration of liraglutide ameliorates learning and memory impairment by modulating tau hyperphosphorylation via the glycogen synthase kinase-3\u03b2 pathway in an amyloid \u03b2 protein induced alzheimer disease mouse model","volume":"783","author":"Qi","year":"2016","journal-title":"Eur. J. Pharm."},{"key":"10.1016\/j.arr.2025.103001_bib114","doi-asserted-by":"crossref","first-page":"41","DOI":"10.4088\/JCP.v66n0106","article-title":"Depression During Pegylated Interferon-Alpha Plus Ribavirin Therapy: Prevalence and Prediction","volume":"66","author":"Raison","year":"2005","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.arr.2025.103001_bib115","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1001\/2013.jamapsychiatry.4","article-title":"A Randomized Controlled Trial of the Tumor Necrosis Factor Antagonist Infliximab for Treatment-Resistant Depression: The Role of Baseline Inflammatory Biomarkers","volume":"70","author":"Raison","year":"2013","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.arr.2025.103001_bib116","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1002\/ana.26465","article-title":"Microglial Activation and Connectivity in Alzheimer Disease and Aging","volume":"92","author":"Rauchmann","year":"2022","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.arr.2025.103001_bib117","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1093\/hmg\/ddx052","article-title":"Mitochondria-targeted small molecule SS31: a potential candidate for the treatment of Alzheimer\u2019s disease","volume":"26","author":"Reddy","year":"2017","journal-title":"Hum. Mol. Genet"},{"key":"10.1016\/j.arr.2025.103001_bib118","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2023.106106","article-title":"Lamotrigine rescues neuronal alterations and prevents seizure-induced memory decline in an Alzheimer\u2019s disease mouse model","volume":"181","author":"Rizzello","year":"2023","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.arr.2025.103001_bib119","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2022.864514","article-title":"Synaptic Vesicle Glycoprotein 2A: Features and Functions","volume":"16","author":"Rossi","year":"2022","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.arr.2025.103001_bib120","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1038\/s41593-018-0128-y","article-title":"Maternal IL-6 during pregnancy can be estimated from newborn brain connectivity and predicts future working memory in offspring","volume":"21","author":"Rudolph","year":"2018","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.arr.2025.103001_bib121","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1121081109","article-title":"Levetiracetam suppresses neuronal network dysfunction and reverses synaptic and cognitive deficits in an Alzheimer\u2019s disease model","volume":"109","author":"Sanchez","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.arr.2025.103001_bib122","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1056\/NEJMoa030815","article-title":"Infliximab Maintenance Therapy for Fistulizing Crohn\u2019s Disease","volume":"350","author":"Sands","year":"2004","journal-title":"N. Engl. J. Med"},{"key":"10.1016\/j.arr.2025.103001_bib123","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1002\/hbm.23148","article-title":"Ketamine administration reduces amygdalo-hippocampal reactivity to emotional stimulation","volume":"37","author":"Scheidegger","year":"2016","journal-title":"Hum. Brain Mapp."},{"key":"10.1016\/j.arr.2025.103001_bib124","doi-asserted-by":"crossref","first-page":"4323","DOI":"10.1523\/JNEUROSCI.3263-16.2017","article-title":"Phases of hyperconnectivity and hypoconnectivity in the default mode and salience networks track with amyloid and tau in clinically normal individuals","volume":"37","author":"Schultz","year":"2017","journal-title":"J. Neurosci."},{"key":"10.1016\/j.arr.2025.103001_bib125","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/s41398-023-02616-x","article-title":"Metformin improves cognitive impairment in patients with schizophrenia: associated with enhanced functional connectivity of dorsolateral prefrontal cortex","volume":"13","author":"Shao","year":"2023","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.arr.2025.103001_bib126","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.brainres.2010.10.053","article-title":"Anti-TNF-\u03b1 reduces amyloid plaques and tau phosphorylation and induces CD11c-positive dendritic-like cell in the APP\/PS1 transgenic mouse brains","volume":"1368","author":"Shi","year":"2011","journal-title":"Brain Res"},{"key":"10.1016\/j.arr.2025.103001_bib127","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1111\/j.1532-5415.2011.03445.x","article-title":"Cognitive improvement with intrathecal administration of infliximab in a woman with Alzheimer\u2019s disease","volume":"59","author":"Shi","year":"2011","journal-title":"J. Am. Geriatr. Soc."},{"key":"10.1016\/j.arr.2025.103001_bib128","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/s41586-024-07624-5","article-title":"Psilocybin desynchronizes the human brain","volume":"632","author":"Siegel","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.arr.2025.103001_bib129","doi-asserted-by":"crossref","first-page":"4479","DOI":"10.1038\/s41598-021-83994-4","article-title":"Effects of the antibiotic rifaximin on cortical functional connectivity are mediated through insular cortex","volume":"11","author":"Sometti","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.arr.2025.103001_bib130","article-title":"Probing gut-brain links in Alzheimer\u2019s disease with rifaximin","volume":"8","author":"Suhocki","year":"2022","journal-title":"AD Transl. Res Clin. Inter."},{"key":"10.1016\/j.arr.2025.103001_bib131","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1093\/brain\/awad366","article-title":"Metformin in elderly type 2 diabetes mellitus: dose-dependent dementia risk reduction","volume":"147","author":"Sun","year":"2024","journal-title":"Brain"},{"key":"10.1016\/j.arr.2025.103001_bib132","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.cub.2015.01.016","article-title":"Sleep Interacts with A\u03b2 to Modulate Intrinsic Neuronal Excitability","volume":"25","author":"Tabuchi","year":"2015","journal-title":"Curr. Biol."},{"key":"10.1016\/j.arr.2025.103001_bib133","doi-asserted-by":"crossref","first-page":"706","DOI":"10.14283\/jpad.2023.113","article-title":"Metformin in the Prevention of Alzheimer\u2019s Disease and Alzheimer\u2019s Disease Related Dementias","volume":"10","author":"Tahmi","year":"2023","journal-title":"J. Prev. Alzheimers Dis."},{"key":"10.1016\/j.arr.2025.103001_bib134","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1742-2094-5-2","article-title":"Rapid cognitive improvement in Alzheimer\u2019s disease following perispinal etanercept administration","volume":"5","author":"Tobinick","year":"2008","journal-title":"J. Neuroinflamm."},{"key":"10.1016\/j.arr.2025.103001_bib135","doi-asserted-by":"crossref","first-page":"9318","DOI":"10.3390\/ijms21239318","article-title":"Modulation of Brain Hyperexcitability: Potential New Therapeutic Approaches in Alzheimer\u2019s Disease","volume":"21","author":"Toniolo","year":"2020","journal-title":"IJMS"},{"key":"10.1016\/j.arr.2025.103001_bib136","doi-asserted-by":"crossref","first-page":"619","DOI":"10.3233\/JAD-200711","article-title":"Therapeutic potential of TNF-\u03b1 inhibition for Alzheimer\u2019s disease prevention","volume":"78","author":"Torres-Acosta","year":"2020","journal-title":"JAD"},{"key":"10.1016\/j.arr.2025.103001_bib137","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.bbi.2014.05.007","article-title":"Evidence for increased microglial priming and macrophage recruitment in the dorsal anterior cingulate white matter of depressed suicides","volume":"42","author":"Torres-Platas","year":"2014","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.arr.2025.103001_bib138","article-title":"A randomized proof-of-mechanism trial of TNF antagonism for motivational deficits and related corticostriatal circuitry in depressed patients with high inflammation","author":"Treadway","year":"2024","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.arr.2025.103001_bib139","article-title":"Data-driven discovery of associations between prescribed drugs and dementia risk: A systematic review","volume":"11","author":"Underwood","year":"2025","journal-title":"AD Transl. Res Clin. Inter."},{"key":"10.1016\/j.arr.2025.103001_bib140","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1111\/dom.15363","article-title":"Semaglutide, suicidal ideation and behaviour: a resting state functional magnetic resonance imaging perspective","volume":"26","author":"Verovnik","year":"2024","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.arr.2025.103001_bib141","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s13195-018-0413-8","article-title":"Cerebrovascular disease influences functional and structural network connectivity in patients with amnestic mild cognitive impairment and Alzheimer\u2019s disease","volume":"10","author":"Vipin","year":"2018","journal-title":"Alz Res Ther."},{"key":"10.1016\/j.arr.2025.103001_bib142","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1038\/s41583-023-00731-8","article-title":"Connectome-based modelling of neurodegenerative diseases: towards precision medicine and mechanistic insight","volume":"24","author":"Vogel","year":"2023","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.arr.2025.103001_bib143","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1001\/jamaneurol.2021.3310","article-title":"Effect of Levetiracetam on Cognition in Patients With Alzheimer Disease With and Without Epileptiform Activity: A Randomized Clinical Trial","volume":"78","author":"Vossel","year":"2021","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.arr.2025.103001_bib144","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S1474-4422(17)30044-3","article-title":"Epileptic activity in Alzheimer\u2019s disease: causes and clinical relevance","volume":"16","author":"Vossel","year":"2017","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.arr.2025.103001_bib145","first-page":"1","article-title":"Lamotrigine Reduces Inflammatory Response and Ameliorates Executive Function Deterioration in an Alzheimer\u2019s-Like Mouse Model","volume":"2016","author":"Wang","year":"2016","journal-title":"BioMed. Res. Int."},{"key":"10.1016\/j.arr.2025.103001_bib146","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2023.109716","article-title":"Semaglutide ameliorates cognition and glucose metabolism dysfunction in the 3xTg mouse model of Alzheimer\u2019s disease via the GLP-1R\/SIRT1\/GLUT4 pathway","volume":"240","author":"Wang","year":"2023","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.arr.2025.103001_bib147","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.bbr.2018.08.006","article-title":"Neural correlates of liraglutide effects in persons at risk for Alzheimer\u2019s disease","volume":"356","author":"Watson","year":"2019","journal-title":"Behav. Brain Res"},{"key":"10.1016\/j.arr.2025.103001_bib148","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1111\/epi.14448","article-title":"Effects of carbamazepine and lamotrigine on functional magnetic resonance imaging cognitive networks","volume":"59","author":"Xiao","year":"2018","journal-title":"Epilepsia"},{"key":"10.1016\/j.arr.2025.103001_bib149","doi-asserted-by":"crossref","first-page":"6358","DOI":"10.1016\/j.cell.2024.08.021","article-title":"Metformin decelerates aging clock in male monkeys","volume":"187","author":"Yang","year":"2024","journal-title":"Cell"},{"key":"10.1016\/j.arr.2025.103001_bib150","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1016\/j.neuroimage.2010.03.040","article-title":"High-resolution structural and functional MRI of hippocampal CA3 and dentate gyrus in patients with amnestic Mild Cognitive Impairment","volume":"51","author":"Yassa","year":"2010","journal-title":"NeuroImage"},{"key":"10.1016\/j.arr.2025.103001_bib151","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.cmet.2016.09.003","article-title":"Metformin Activates AMPK through the Lysosomal Pathway","volume":"24","author":"Zhang","year":"2016","journal-title":"Cell Metab."},{"key":"10.1016\/j.arr.2025.103001_bib152","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/nrneurol.2009.198","article-title":"Disease and the brain\u2019s dark energy","volume":"6","author":"Zhang","year":"2010","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.arr.2025.103001_bib153","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.4103\/1673-5374.390982","article-title":"A divergent pattern in functional connectivity: a transdiagnostic perspective","volume":"19","author":"Zhang","year":"2024","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.arr.2025.103001_bib154","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.117540","article-title":"Semaglutide ameliorates Alzheimer\u2019s disease and restores oxytocin in APP\/PS1 mice and human brain organoid models","volume":"180","author":"Zhang","year":"2024","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.arr.2025.103001_bib155","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2022.888784","article-title":"Levetiracetam alleviates cognitive decline in Alzheimer\u2019s disease animal model by ameliorating the dysfunction of the neuronal network","volume":"14","author":"Zheng","year":"2022","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.arr.2025.103001_bib156","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1093\/brain\/awq075","article-title":"Divergent network connectivity changes in behavioural variant frontotemporal dementia and Alzheimer\u2019s disease","volume":"133","author":"Zhou","year":"2010","journal-title":"Brain"},{"key":"10.1016\/j.arr.2025.103001_bib157","article-title":"Tumor Necrosis Factor (TNF) blocking agents are associated with lower risk for Alzheimer\u2019s disease in patients with rheumatoid arthritis and psoriasis","volume":"15","author":"Zhou","year":"2020","journal-title":"PLoS ONE"},{"key":"10.1016\/j.arr.2025.103001_bib158","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.39723","article-title":"Metformin Cessation and Dementia Incidence","volume":"6","author":"Zimmerman","year":"2023","journal-title":"JAMA Netw. Open"}],"container-title":["Ageing Research Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568163725003472?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568163725003472?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T23:36:30Z","timestamp":1781220990000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568163725003472"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":158,"alternative-id":["S1568163725003472"],"URL":"https:\/\/doi.org\/10.1016\/j.arr.2025.103001","relation":{},"ISSN":["1568-1637"],"issn-type":[{"value":"1568-1637","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting brain connectivity in Alzheimer\u2019s disease with repurposed drugs","name":"articletitle","label":"Article Title"},{"value":"Ageing Research Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arr.2025.103001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"103001"}}